Access your personal account.


Take the first step. Support Personalized Medicine.


Pharmacogenomics Advisory Group (PAG)

Issam Zineh, Pharm.D., M.P.H. Issam Zineh, Pharm.D., M.P.H., is the PAG chair. Dr. Zineh is Associate Director for Genomics in the Office of Clinical Pharmacology at CDER, FDA, as well as an internationally recognized expert in the field of pharmacogenetics. He is also chair of the Pharmacogenetics and Molecular Pharmacology and Pharmacogenetics Scientific Section of the American Society for Clinical Pharmacology and Therapeutics.
Marialice Bennett, B.S., RP.h. Marialice Bennett, B.S., RP.h., is a Professor of Clinical Pharmacy at the Ohio State University College of Pharmacy. She also serves as a co-founder and pharmacy director for University Health Connection, an innovative interprofessional healthcare clinic for faculty and staff of the university. Dr. Bennett was elected as the 2010-2011 President-Elect of the American Pharmacist Association.
Arthur L. Caplan, Ph.D. Arthur L. Caplan, Ph.D., is currently the Emmanuel and Robert Hart Director of the Center for Bioethics and the Sydney D. Caplan Professor of Bioethics at the University of Pennsylvania in Philadelphia. An expert in the field of Bioethics, he has written or edited twenty-nine books and served on a number of national and international committees. He was described as one of the ten most influential people in science by Discover magazine in 2008.
Michael D. Ezekowitz, M.B., Ch.B., D.Phil. Michael D. Ezekowitz, M.B., Ch.B., D.Phil., is a professor and Vice President of the Lankenau Institute for Medical Research, as well as the Vice President of Clinical Research for Main Line Hospitals. Dr. Ezekowitz is an active non-invasive clinical cardiologist and has been involved in the design and conduct of numerous large clinical trials.
David Flockhart, M.D., Ph.D. David Flockhart, M.D., Ph.D., is the Chief of the Division of Clinical Pharmacology at the Indiana University School of Medicine where he is also the Director of the Indiana Institute for Personalized Medicine. His research is focused on clinically-relevant applications of pharmacogenetics and drug interactions.
Andrew K. Godwin, Ph.D. Andrew K. Godwin, Ph.D., is a Chancellors Distinguished Chair in Biomedical Sciences endowed Professor. He is also Professor in the Department of Pathology & Laboratory Medicine at the University of Kansas Medical Center and their Director of Molecular Oncology. Dr. Godwin plays a role in the University of Kansas Cancer Center as the Associate Director for Translation Research.
Amalia Issa, M.P.H., Ph.D. Amalia Issa, M.P.H., Ph.D., is the Founding Director of the Program in Personalized Medicine and Targeted Therapeutics (P2MT2), as well as an Associate Professor at the College of Pharmacy at the University of Houston. Since 1998, Dr. Issa has developed a unique area of translational research focused on pharmacogenomics and personalized medicine applications, and how they will be translated and integrated into health care delivery and health systems.
Teri E. Klein, Ph.D. Teri E. Klein, Ph.D., is a senior scientist at Stanford University, where her research interests cover the broad spectrum of pharmacogenetics, computational biology, and bioinformatics. She is also the Director for the PharmGKB (Pharmacogenomics Knowledge Base) and the co-founder and co-chair of the Pacific Symposium on Biocomputing.
Calvin H. Knowlton, BSPharm, MDiv, Ph.D. Calvin H. Knowlton, BSPharm, MDiv, Ph.D., is the founder and CEO of RevolutionCare, Inc., a group that provides home-based primary care services, and of CareKinesis, Inc., which provides medication therapy management and pharmacogenomics translation for elderly patients and physicians. Dr. Knowlton has an expansive entrepreneurial career, founding many other successful healthcare companies including excelleRx, a national hospice-focused medication management firm.
Howard McLeod, Pharm.D. Howard McLeod, Pharm.D., is the Fred Eshelman Distinguished Professor in the Division of Pharmacotherapy and Experimental Therapeutics at the University of North Carolina at Chapel Hill, as well as the director of the UNC Institute for Pharmacogenomics and Individualized Therapy. Dr. McLeod is also the Principal Investigator for CREATE, a member of the NIH-funded Pharmacogenetics Research Network and is a member of the FDA committee on Clinical Pharmacology.
Steven Murphy, M.D. Steven Murphy, M.D., is the Managing Partner and President of The Personalized Medicine Group in New York, NY, and Greenwich, CT. He serves on the faculty at New York Medical College as an Instructor in the Department of Cell Biology and Anatomy. Dr. Murphy is a thought leader in personalized medicine and the author of “Gene Sherpas: Personalized Medicine and You,” a popular personalized medicine blog.
Michael F. Murray, M.D. Michael F. Murray, M.D., is Director of the General Genetics Clinic and Clinical Chief of the Genetics Division in the Department of Medicine at Brigham and Women's Hospital. Dr. Murray is also an instructor in medicine at Harvard Medical School. He directs the combined internal medicine-medical genetics residency and runs an annual course on the “genetic and genomic basis of adult medicine”.
Michael S. Phillips, Ph.D. Michael S. Phillips, Ph.D., is the recipient of a federal Canada Research Chair in Translational Pharmacogenomics and an Associate Professor in the Faculty of Medicine at the Université de Montréal. He is also the Director the Beaulieu-Saucier Université de Montréal Pharmacogenomics Centre which supports the integration of pharmacogenomics into Clinical Trials and Healthcare.
Wolfgang Sadee, Dr.rer.nat. Wolfgang Sadee, Dr.rer.nat., is the Felts Mercer Professor of Medicine and Pharmacology at Ohio State University Medical Center. He is also the chair of the Department of Pharmacology; a Professor of pharmacy, psychiatry and medical genetics; and the Director of the OSU Program in Pharmacogenomics.